Cargando…

564. Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19

BACKGROUND: Frequent observation of increasing fever and rising inflammatory markers late after onset of COVID-19 suggests Cytokine Release Syndrome (CRS, “Cytokine Storm”) may contribute to pathophysiology. Tocilizumab (TCZ), a monoclonal antibody targeting the receptor for the pro-inflammatory cyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colgrove, Robert, Morin, Scott, Jani, Chinmay, Rupal, Arashdeep, Bourque, Daniel L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776910/ http://dx.doi.org/10.1093/ofid/ofaa439.758

Ejemplares similares

2028. ID Consultant EMR Hyperlinked Recommendation as a Tool to Curb “Routine” Following of Inflammatory Markers
por: Colgrove, Robert
Publicado: (2018)

564. SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus Immunogenicity
por: Joyce, M G, et al.
Publicado: (2021)

Food Coma: Hyperammonemic Encephalopathy From Refeeding Syndrome
por: Khoory, Joseph, et al.
Publicado: (2021)

564. Nocardiosis in Portugal: a single-center experience
por: Besteiro, Bruno, et al.
Publicado: (2023)

P564: HOMOHARRINGTONINE AND CYTARABINE COMBINED WITH VENETOCLAX (HAV) FOR ADULT PATIENTS WITH DE NOVO AML
por: Luo, Xiao-Hua, et al.
Publicado: (2023)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

Patent Foramen Ovale and Ascending Aortic Dilatation Causing Platypnea-Orthodeoxia Syndrome
por: Ahmed, Alaaeldin, et al.
Publicado: (2022)

56.4 Accomplishing Change in This Digital World
por: Krakower, Scott
Publicado: (2022)

PT564. Involvement of astrocyte-neuron lactate shuttle dysfunction in the cognitive impairment in diabetic mice
por: Maruoka, Junya, et al.
Publicado: (2016)

564. Higher “No Show” Rates Are Associated with Lower Rates of Retention in HIV Care and Viral Suppression
por: Althoff, Amy, et al.
Publicado: (2018)

A rare etiology of pulmonary nodules
por: Rupal, Arashdeep, et al.
Publicado: (2021)

564. Patient and Prescriber Characteristics Associated with Inappropriately Long Antibiotic Duration for Skin and Soft Tissue Infections
por: Broussard, Kali, et al.
Publicado: (2022)

563. Tocilizumab in the Treatment of Critical COVID-19 Pneumonia
por: Fisher, Matthew, et al.
Publicado: (2020)

Sustained remission of Multicentric Castleman Disease in children treated with tocilizumab
por: Galeotti, C, et al.
Publicado: (2011)

566. Tocilizumab: A Friend or a Foe in COVID-19 Management?
por: Hernandez, Jarelys M, et al.
Publicado: (2020)

342. Secondary Infections following Tocilizumab for Treatment of COVID-19 Pneumonia
por: Warner, Adam, et al.
Publicado: (2021)

564 Comparison of clinical outcomes in pregnant women with and without COVID-19 based on disease severity
por: Gold, Stacey, et al.
Publicado: (2021)

565. Tocilizumab Use in COVID-19: Act(emra) to Inhibit Intubation and Decompensation
por: Willner, Debra M, et al.
Publicado: (2020)

564 Simplified Dynamic Splints for Common Scar Contractures of the Hand
por: Andre, Gregory, et al.
Publicado: (2023)

564 Is It Really Difficult-to-treat Asthma? Don't Forget Other Causes of Wheeze
por: Kalkan, Ilkay Koca, et al.
Publicado: (2012)

400. Secondary Infections in COVID-19 Patients Receiving Tocilizumab in a Community Hospital
por: Usiak, Shauna, et al.
Publicado: (2020)

304. Impact of Antibiotic Prophylaxis Prior to Treatment with Steroids and Tocilizumab in COVID-19 Patients
por: de Novales, Francisco Javier Membrillo, et al.
Publicado: (2021)

28. Acute gout with normal inflammatory markers in a seropositive rheumatoid arthritis on longstanding tocilizumab.
por: Levasseur, Kirsty, et al.
Publicado: (2017)

550. Clinical impact of Tocilizumab therapy in SARS-CoV-2 respiratory infections in ICU and non-ICU patients
por: Vyas, Nikunj M, et al.
Publicado: (2020)

554. Early Clinical Outcomes with Tocilizumab for Covid-19: A Two-Center Retrospective Study
por: Smoke, Steven, et al.
Publicado: (2020)

562. Tocilizumab for the Treatment of Severe COVID-19: A Retrospective, Multi-Center, Case-Matched Series
por: Norman, Sarah, et al.
Publicado: (2020)

539. Impact of Corticosteroids when Combined with Tocilizumab or Remdesivir for the Treatment of Severe SARS-CoV-2
por: Rosati, Michael, et al.
Publicado: (2021)

341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab
por: Barsoum, Barbara, et al.
Publicado: (2021)

KEYNOTE-564: Adjuvant immunotherapy for renal cell carcinoma
por: Pandey, Abhishek
Publicado: (2022)

Relationship Between Levels of Inflammatory Markers and Severity of Mania
por: Kumari, Shalini, et al.
Publicado: (2022)

551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

564. A Five-Year Evolutionary Study of the Minimum Inhibitory Concentrations of Methicillin-resistant Staphylococcus aureus to Mupirocin, Chlorhexidine, and Octenidine in a Singaporean Tertiary Institution
por: Zheng, Shuwei, et al.
Publicado: (2019)

P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY
por: Yokoyama, Shota, et al.
Publicado: (2023)

West Nile virus: another emerging arboviral risk for travelers?
por: Jani, Chinmay, et al.
Publicado: (2022)

564 The Impact of COVID-19 on the Provision of Pediatric Burn Care
por: Chakera, Hawwa, et al.
Publicado: (2022)

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers
por: Rubio-Rivas, Manuel, et al.
Publicado: (2021)

562. Tocilizumab Use in the Second Trimester Pregnant Patients with Severe Covid-19 Pneumonia and their Maternal and Fetal Outcomes: Two Case Reports
por: iqbal, Fatima, et al.
Publicado: (2021)

534. The Use of Tocilizumab and Remdesivir in SARS- CoV-2 Patients in El Paso Texas: A Longitudinal Comparative Observational Study
por: Almaghlouth, Nouf K, et al.
Publicado: (2021)

297. Infectious Complications Associated with Tocilizumab Use in Patients Infected with SARS-CoV-2 at a Mid-Atlantic Hospital Consortium
por: Kent, Kristen R, et al.
Publicado: (2021)

422. Sustainability of Improvements to Hand Hygiene Performance Throughout the COVID-19 Pandemic
por: Williams, Victoria R, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ki5fs15ae8332ahl236tf60c6